We are live on
!
Find out more
EV
Eclipse Ventures Portfolio holdings
AUM
$2.57B
This Fund
S&P 500
This Quarter
Est. Return
+30.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$599M
AUM Growth
–
Cap. Flow
+$635M
Cap. Flow
% of AUM
106.02%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enovix
ENVX
|
+$487M |
| 2 |
Owlet
OWLT
|
+$109M |
| 3 |
LHDX
Lucira Health, Inc. Common Stock
LHDX
|
+$39.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 79.62% |
| 2 | Healthcare | 20.38% |
Similar funds
RFP
PC
MC
TC
CL
CTA
PI
SCA
Eclipse Ventures's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Eclipse Ventures, which disclosed 3 positions worth $599M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Enovix: 20,095,152 shares worth $477M.
By sector, the portfolio is most concentrated in Industrials at 80% of assets, followed by Healthcare.
- Eclipse Ventures's largest Q4 2021 buy was Enovix: 20,095,152 shares worth $477M.
- Eclipse Ventures's ten largest holdings make up 100% of its $599M portfolio in Q4 2021.
- Eclipse Ventures disclosed 3 positions in Q4 2021, its first 13F filing on record.
Based on Eclipse Ventures's 13F filing for Q4 2021, filed 9 Feb 2022.